Sampath Kumar

Sampath Kumar

Auto-generated profile, based on publicly available information

Sampath Kumar

Department of Biomedical Sciences, College of Medicine, Florida State University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2021 in Frontiers in Synaptic Neuroscience
Verified
Journal Article
Open access
SKSampath Kumar
Sampath Kumar
SKSanjay S. Kumar
Sanjay S. Kumar
Glutamatergic AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) and NMDA (N-methyl-D-aspartate) receptors are implicated in diverse functions ranging from synaptic plasticity to cell death. They are heterotetrameric proteins whose subunits are derived from multiple distinct gene families. The subunit composition of these receptors determines their permeability to monovalent and/or divalent cations, but it is not entirely clear how this selectivity arises in native and recombinantly-expressed receptor populations. By analyzing the sequence of amino acids lining the selectivity filters within the pore forming membrane helices (M2) of these subunits and by correlating subunit stoichiometry of these receptors with their ability to permeate Na+ and/or Ca2+, we propose here a mathematical model for predicting cation selectivity and permeability in these receptors. The model proposed is based on principles of charge attractivity and charge neutralization within the pore forming region of these receptors; it accurately predicts and reconciles experimental data across various platforms including Ca2+ permeability of GluA2-lacking AMPARs and ion selectivity within GluN3-containing di- and tri-heteromeric NMDARs. Additionally, the model provides insights into biophysical mechanisms regulating cation selectivity and permeability of these receptors and the role of various subunits in these processes.

9 January 2025 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
HLHanzhou Li
Hanzhou Li
JMJohn Timothy Moon
John Timothy Moon
SKSampath Kumar
Sampath Kumar
JRJulian Ricci
Julian Ricci
NSNathan Sim
Nathan Sim
JGJudy W. Gichoya
Judy W. Gichoya

13 November 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
GXGengqiang Xie
Gengqiang Xie
LZLiting Zhang
Liting Zhang
OUOlalekan H Usman
Olalekan H Usman
SKSampath Kumar
Sampath Kumar
CMChaity Modak
Chaity Modak
JIJerome Irianto
Jerome Irianto
Objectives: To evaluate the suitability of the MIA PaCa-2 cell line for studying pancreatic cancer intratumor heterogeneity, we aim to further characterize the nature of MIA PaCa-2 cells’ phenotypic, genomic, and transcriptomic heterogeneity. Methods: MIA PaCa-2 single-cell clones were established through flow cytometry. For the phenotypic study, we quantified the cellular morphology, proliferation rate, migration potential, and drug sensitivity of the clones. The chromosome copy number and transcriptomic profiles were quantified using SNPa and RNA-seq, respectively. Results: Four MIA PaCa-2 clones showed distinctive phenotypes, with differences in cellular morphology, proliferation rate, migration potential, and drug sensitivity. We also observed a degree of genomic variations between these clones in form of chromosome copy number alterations and single nucleotide variations, suggesting the genomic heterogeneity of the population, and the intrinsic genomic instability of MIA PaCa-2 cells. Lastly, transcriptomic analysis of the clones also revealed gene expression profile differences between the clones, including the uniquely regulated ITGAV , which dictates the morphology of MIA PaCa-2 clones. Conclusions: MIA PaCa-2 is comprised of cells with distinctive phenotypes, heterogeneous genomes, and differential transcriptomic profiles, suggesting its suitability as a model to study the underlying mechanisms behind pancreatic cancer heterogeneity.

13 November 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
OUOlalekan H Usman
Olalekan H Usman
SKSampath Kumar
Sampath Kumar
RWReddick R Walker
Reddick R Walker
GXGengqiang Xie
Gengqiang Xie
HSHyeje Sumajit
Hyeje Sumajit
JIJerome Irianto
Jerome Irianto
Pancreatic cancer adenocarcinoma (PDAC) is reported to be the third highest cause of cancer-related deaths in the United States. PDAC is known for its high proportion of stroma, which accounts for 90% of the tumor mass. The stroma is made up of extracellular matrix (ECM) and non-malignant cells such as inflammatory cells, cancer-associated fibroblasts, and lymphatic and blood vessels. Here, we decoupled the effects of the ECM on PDAC cell lines by culturing cells on surfaces coated with different ECM proteins. Our data show that the primary tumor-derived cell lines have different morphology depending on the ECM proteins on which they are cultured, while metastatic lesion-derived PDAC lines’ morphology does not change with respect to the different ECM proteins. Similarly, ECM proteins modulate the proliferation rate and the gemcitabine sensitivity of the primary tumor PDAC cell lines, but not the metastatic PDAC lines. Lastly, transcriptomics analysis of the primary tumor PDAC cells cultured on different ECM proteins reveals the regulation of various pathways, such as cell cycle, cell adhesion molecules, and focal adhesion, including the regulation of several integrin genes that are essential for ECM recognition.

20 November 2026 in Radiology Case Reports
Verified
Journal Article
Open access
SKSampath Kumar
Sampath Kumar
SDShreya Dunddumalla
Shreya Dunddumalla
MKMaruti Kumaran
Maruti Kumaran